Renaming the SARS-CoV-2 Omicron sublineages as SARS-CoV-3 is contrary to nomenclature standards based on evolutionary and serological evidence
- PMID: 35696595
- PMCID: PMC9191866
- DOI: 10.1002/ctm2.924
Renaming the SARS-CoV-2 Omicron sublineages as SARS-CoV-3 is contrary to nomenclature standards based on evolutionary and serological evidence
Conflict of interest statement
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Figures
Comment on
-
New subvariants are masters of immune evasion.Science. 2022 May 13;376(6594):679-680. doi: 10.1126/science.adc9448. Epub 2022 May 12. Science. 2022. PMID: 35549399
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous